AC Immune (ACIU) Shareholder's Equity Growth (5y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.11% |
| Sep 30, 2025 | -20.98% |
| Jun 30, 2025 | -19.09% |
| Mar 31, 2025 | -17.42% |
| Dec 31, 2024 | -14.18% |
| Sep 30, 2024 | -12.73% |
| Jun 30, 2024 | 246.68% |
| Mar 31, 2024 | -7.35% |
| Dec 31, 2023 | 0.29% |
| Dec 31, 2022 | 8.17% |
| Sep 30, 2022 | 5.86% |
| Jun 30, 2022 | 7.82% |
| Mar 31, 2022 | 11.84% |
| Dec 31, 2021 | 12.06% |
| Sep 30, 2021 | 321.93% |
| Jun 30, 2021 | 326.69% |
| Mar 31, 2021 | 360.14% |
| Dec 31, 2020 | 27.12% |
| Sep 30, 2020 | 24.05% |
| Dec 31, 2019 | 62.43% |